FDA requires lower doses for sleep meds
WASHINGTON -- The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness.
The agency said yesterday that new research shows the drugs remain in the bloodstream at levels high enough to interfere with alertness and coordination, which...